Literature DB >> 31598405

The characterization of lung microbiome in lung cancer patients with different clinicopathology.

Danhui Huang1, Xiaofang Su1, Man Yuan1, Shujia Zhang1, Jing He1, Qiuhua Deng1,2, Wenjun Qiu3, Hangming Dong1, Shaoxi Cai1.   

Abstract

There were few knowledge concerned correlation between lung microbiome and different clinicopathology of lung cancer. Bronchial washing fluid (BWF) and sputum are commonly used sample types but there was no study comparing difference of microbiome between these two in lung cancer. In this study, we aimed to compare difference of microbiome between these two sample types and characterize lung microbiome in squamous cell lung carcinoma with (SCC_M1) or without distant metastasis (SCC_M0) and lung adenocarcinoma with (AD_M1) or without distant metastasis (AD_M0). We collected 40 BWF samples and 52 sputum samples from newly diagnosed lung cancer patients. Bacterial species were sequenced via 16S rRNA sequencing. Phylum Proteobacteria in BWF samples were significantly higher than sputum samples (Wilcoxon test, P = 0.003). At phylum level, microbiome of BWF samples was more similar to that of lung cancer tissues reported in the previous literature. LEFse analysis showed that in BWF group, genera Veillonell, Megasphaera, Actinomyces and Arthrobacter in AD_M0 were significantly higher than those in SCC_M0, and genera Capnocytophaga and Rothia in AD_M1 were significantly lower than that in SCC_M1. Compared with AD_M0, genus Streptococcus of AD_M1 was significantly lower, and genera Veillonella and Rothia in SCC_M1 were significantly higher than that in SCC_M1. Our study suggested that BWF samples might better reflect the microbiome of lung cancer tissues. In different metastatic states of lung cancer, differential genera between squamous cell carcinoma and adenocarcinoma were different. And in different histologic types of lung cancer, distant metastasis-related genera were not the same. AJCR
Copyright © 2019.

Entities:  

Keywords:  16S rRNA; Non-small cell lung cancer; histology; metastasis; microbiome

Year:  2019        PMID: 31598405      PMCID: PMC6780665     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  59 in total

1.  Lung abscess following bronchoscopy due to multidrug-resistant Capnocytophaga sputigena adjacent to lung cancer with high PD-L1 expression.

Authors:  Yohei Migiyama; Moriyasu Anai; Kosuke Kashiwabara; Yusuke Tomita; Sho Saeki; Kazuyoshi Nakamura; Shinichiro Okamoto; Hidenori Ichiyasu; Kazuhiko Fujii; Hirotsugu Kohrogi
Journal:  J Infect Chemother       Date:  2018-04-25       Impact factor: 2.211

2.  IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth.

Authors:  C Jungnickel; L H Schmidt; L Bittigkoffer; L Wolf; A Wolf; F Ritzmann; A Kamyschnikow; C Herr; M D Menger; T Spieker; R Wiewrodt; R Bals; C Beisswenger
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

3.  Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.

Authors:  Jin Wang; Jianxiang Song; Zhengya Gao; Xudong Huo; Yajun Zhang; Wencai Wang; Jianwei Qi; Shiying Zheng
Journal:  Oncol Rep       Date:  2017-01-17       Impact factor: 3.906

4.  Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.

Authors:  Jérôme Biton; Hanane Ouakrim; Agnès Dechartres; Marco Alifano; Audrey Mansuet-Lupo; Han Si; Rebecca Halpin; Todd Creasy; Claudie Bantsimba-Malanda; Jennifer Arrondeau; François Goldwasser; Pascaline Boudou-Rouquette; Ludovic Fournel; Nicolas Roche; Pierre-Régis Burgel; Jeremy Goc; Priyanka Devi-Marulkar; Claire Germain; Marie-Caroline Dieu-Nosjean; Isabelle Cremer; Ronald Herbst; Diane Damotte
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

5.  Anaerobic bacteria colonizing the lower airways in lung cancer patients.

Authors:  Pawel Rybojad; Renata Los; Marek Sawicki; Jacek Tabarkiewicz; Anna Malm
Journal:  Folia Histochem Cytobiol       Date:  2011       Impact factor: 1.698

6.  16S rDNA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary disease.

Authors:  L Tan; H Wang; C Li; Y Pan
Journal:  J Periodontal Res       Date:  2014-02-01       Impact factor: 4.419

7.  Cigarette smoke-induced disruption of pulmonary barrier and bacterial translocation drive tumor-associated inflammation and growth.

Authors:  C Jungnickel; B Wonnenberg; O Karabiber; A Wolf; M Voss; L Wolf; A Honecker; A Kamyschnikow; C Herr; R Bals; C Beisswenger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-24       Impact factor: 5.464

8.  Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Authors:  Tony S Mok; Yi-Long Wu; Sumitra Thongprasert; Chih-Hsin Yang; Da-Tong Chu; Nagahiro Saijo; Patrapim Sunpaweravong; Baohui Han; Benjamin Margono; Yukito Ichinose; Yutaka Nishiwaki; Yuichiro Ohe; Jin-Ji Yang; Busyamas Chewaskulyong; Haiyi Jiang; Emma L Duffield; Claire L Watkins; Alison A Armour; Masahiro Fukuoka
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

9.  Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

Authors:  Morten Busk; Michael R Horsman; Steen Jakobsen; Johan Bussink; Albert van der Kogel; Jens Overgaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

10.  Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway.

Authors:  Mio Ikebe; Yoshiki Kitaura; Masafumi Nakamura; Haruo Tanaka; Akio Yamasaki; Shuntaro Nagai; Junji Wada; Kosuke Yanai; Kenichiro Koga; Norihiro Sato; Makoto Kubo; Masao Tanaka; Hideya Onishi; Mitsuo Katano
Journal:  J Surg Oncol       Date:  2009-12-15       Impact factor: 3.454

View more
  19 in total

1.  The microbiome of lung cancer tissue and its association with pathological and clinical parameters.

Authors:  Ock-Hwa Kim; Bo-Yun Choi; Dong Kwan Kim; Na Hyun Kim; Jin Kyung Rho; Woo Jun Sul; Sei Won Lee
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.

Authors:  Anna Grenda; Ewelina Iwan; Izabela Chmielewska; Paweł Krawczyk; Aleksandra Giza; Arkadiusz Bomba; Małgorzata Frąk; Anna Rolska; Michał Szczyrek; Robert Kieszko; Tomasz Kucharczyk; Bożena Jarosz; Dariusz Wasyl; Janusz Milanowski
Journal:  AMB Express       Date:  2022-07-06       Impact factor: 4.126

Review 3.  The state of the art for artificial intelligence in lung digital pathology.

Authors:  Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Pathol       Date:  2022-06-20       Impact factor: 9.883

4.  Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer.

Authors:  Chen Cheng; Zhifeng Wang; Jingqiao Wang; Chao Ding; Chuang Sun; Pingli Liu; Xiaoqiang Xu; Yanan Liu; Bi Chen; Bing Gu
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 5.  Airway Microbiota as a Modulator of Lung Cancer.

Authors:  Taichiro Goto
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 6.  Microbiome dysbiosis in lung cancer: from composition to therapy.

Authors:  Ning-Ning Liu; Qiang Ma; Yang Ge; Cheng-Xiang Yi; Lu-Qi Wei; Jing-Cong Tan; Qiao Chu; Jing-Quan Li; Peng Zhang; Hui Wang
Journal:  NPJ Precis Oncol       Date:  2020-12-10

7.  Microbiota Biomarkers for Lung Cancer.

Authors:  Qixin Leng; Van K Holden; Janaki Deepak; Nevins W Todd; Feng Jiang
Journal:  Diagnostics (Basel)       Date:  2021-02-27

8.  [Progress of Research on the Relationship between Lung Microbiome and Lung Cancer].

Authors:  Zheng Su; Xinhua Jia; Yaguang Fan; Fanghui Zhao; Youlin Qiao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-01-20

9.  Lung Microbiome Differentially Impacts Survival of Patients with Non-Small Cell Lung Cancer Depending on Tumor Stroma Phenotype.

Authors:  Olga Kovaleva; Polina Podlesnaya; Madina Rashidova; Daria Samoilova; Anatoly Petrenko; Irina Zborovskaya; Valeria Mochalnikova; Vladimir Kataev; Yuri Khlopko; Andrey Plotnikov; Alexei Gratchev
Journal:  Biomedicines       Date:  2020-09-13

Review 10.  Human Gut Microbiota in Health and Selected Cancers.

Authors:  Aleksandra Sędzikowska; Leszek Szablewski
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.